by Jessica Casebolt | Mar 11, 2024 | Access & Coverage, Tea Leaves
A federal appeals court on Tuesday ruled that Texas can prohibit emergency abortions despite the Biden administration arguing that federal guidance trumps state laws. The suit, brought by the state of Texas in 2022, argues that the Department of Health and Human...
by Jessica Casebolt | Mar 11, 2024 | Public Health/Prevention, Tea Leaves
Federal officials are seizing more shipments of unauthorized electronic cigarettes at U.S. ports, but thousands of new flavored products continue pouring into the country from China, according to government and industry data reviewed by The Associated Press. The...
by Jessica Casebolt | Mar 11, 2024 | Providers, Tea Leaves
According to a new report from Fitch Ratings, the labor outlook is stabilizing for U.S. nonprofit hospitals as employment increases and health care job openings decline. According to the credit ratings agency, hospital and ambulatory health care services payrolls have...
by Jessica Casebolt | Mar 11, 2024 | Opioid/Substance Use Disorders, Tea Leaves
Consulting giant McKinsey & Company agreed to a $78 million settlement in a case over its role in advising opioid manufacturers to design misleading marketing campaigns. A group of U.S. health insurers and company benefit plans, referred to in court documents as...
by Jessica Casebolt | Mar 11, 2024 | Life Sciences, Tea Leaves
The U.S. Food and Drug Administration (FDA) said it has seized “thousands of units” of counterfeit Ozempic, the diabetes drug widely used for weight loss, that had been distributed through legitimate drug supply sources. The FDA and the drug’s maker, Novo Nordisk, are...
Recent Comments